-
1دورية أكاديمية
المؤلفون: Smits WK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Vermeulen C; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Hagelaar R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Kimura S; Laboratory of Pathology, St. Jude's Children's Research Hospital, Memphis TN, USA., Vroegindeweij EM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Buijs-Gladdines JGCAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van de Geer E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verstegen MJAM; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands., Splinter E; Cergentis BV, Utrecht, the Netherlands., van Reijmersdal SV; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Buijs A; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Galjart N; Department of Cell Biology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., van Eyndhoven W; Diagnostics and Genomics Group, Agilent Technologies, Amstelveen, the Netherlands., van Min M; Cergentis BV, Utrecht, the Netherlands., Kuiper R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Kemmeren P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Mullighan CG; Laboratory of Pathology, St. Jude's Children's Research Hospital, Memphis TN, USA., de Laat W; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands., Meijerink JPP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: jules.meijerink@acerta-pharma.com.
المصدر: Cell reports [Cell Rep] 2023 Apr 25; Vol. 42 (4), pp. 112373. Date of Electronic Publication: 2023 Apr 14.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Humans ; CCCTC-Binding Factor/genetics ; CCCTC-Binding Factor/metabolism ; Chromatin ; Enhancer Elements, Genetic/genetics ; Mutation ; Oncogenes ; Repressor Proteins/genetics ; Repressor Proteins/metabolism ; Transcription Factors/metabolism ; Tumor Suppressor Proteins/metabolism
-
2دورية أكاديمية
المؤلفون: Li Y; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands., Buijs-Gladdines JG; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Canté-Barrett K; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Stubbs AP; Department of Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands., Vroegindeweij EM; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Smits WK; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Marion R; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands., Dinjens WN; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands., Horstmann M; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Co-operative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Buijsman RC; Netherlands Translational Research Center, Oss, The Netherlands., Zaman GJ; Netherlands Translational Research Center, Oss, The Netherlands., van der Spek PJ; Department of Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands., Pieters R; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Meijerink JP; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
المصدر: PLoS medicine [PLoS Med] 2016 Dec 20; Vol. 13 (12), pp. e1002200. Date of Electronic Publication: 2016 Dec 20 (Print Publication: 2016).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
مواضيع طبية MeSH: Drug Resistance, Neoplasm* , Genome*, Antineoplastic Agents/*pharmacology , Gene Expression Regulation, Neoplastic/*drug effects , Interleukin-7/*genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics , Steroids/*pharmacology, Adolescent ; Child ; Child, Preschool ; Exome ; Humans ; Interleukin-7/metabolism ; Mutation ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/etiology ; Sequence Analysis, DNA